CereVasc
Develops minimally invasive eShunt System to treat communicating hydrocephalus and other neurological diseases
$85MSeries C
Role not disclosedLoading investors…
Activity from announced rounds
Develops minimally invasive eShunt System to treat communicating hydrocephalus and other neurological diseases
Develops interventional therapies for pulmonary hypertension and heart failure
Pitching Medtronic? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room